Loading...

Mckesson Corp
NYSE:MCK

Watchlist Manager
Mckesson Corp Logo
Mckesson Corp
NYSE:MCK
Watchlist
Price: 371.44 USD -2.67% Market Closed
Updated: Dec 10, 2022

Intrinsic Value

The intrinsic value of one MCK stock under the Base Case scenario is 614.47 USD. Compared to the current market price of 371.44 USD, Mckesson Corp is Undervalued by 40%.

The Intrinsic Value is calculated as the average of the two valuation methods:

MCK Intrinsic Value
Base Case
614.47 USD
Undervaluation 40%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

MCK Profitability Score
Profitability Due Diligence

Mckesson Corp's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

36/100
Profitability
Score

Mckesson Corp's profitability score is 36/100. The higher the profitability score, the more profitable the company is.

MCK Solvency Score
Solvency Due Diligence

Mckesson Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Short-Term Liabilities
Long-Term Liabilities
Positive Net Debt
Low D/E
75/100
Solvency
Score

Mckesson Corp's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
5%
Gross Margin
1%
Operating Margin
1%
Net Margin
1%
FCF Margin
-176%
ROE
11%
ROIC
Other

MCK Capital Structure
Mckesson Corp

Market Capitalization 52.7B USD
Total Debt 4.8B USD
Minority Interest 518M USD
Preferred Equity 0 USD
Cash and Equivalents 2.9B USD
Short-Term Investments 0 USD
Enterprise Value 55.2B USD

Wall St
Price Targets

MCK Price Targets Summary
Mckesson Corp

Wall Street analysts forecast MCK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MCK is 423.08 USD with a low forecast of 323.2 USD and a high forecast of 472.5 USD.

Lowest
Price Target
323.2 USD
13% Downside
Average
Price Target
423.08 USD
14% Upside
Highest
Price Target
472.5 USD
27% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

MCK Competitors
Mckesson Corp

MCK Suppliers & Customers
Mckesson Corp

Mckesson Corp has 82 key suppliers from 9 countries and 10 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Pharmaceuticals industry.

United States of America
58
Johnson & Johnson
Pharmaceuticals
Bristol-Myers Squibb Co
Pharmaceuticals
Abbvie Inc
Biotechnology
Pros Holdings Inc
Technology
Amneal Pharmaceuticals Inc
Pharmaceuticals
Biohaven Pharmaceutical Holding Company Ltd
Biotechnology
O
Organon & Co
Pharmaceuticals
Pfizer Inc
Pharmaceuticals
Asana Inc
Technology
Merck & Co Inc
Pharmaceuticals
Healthcare Realty Trust Inc
Real Estate
Eli Lilly and Co
Pharmaceuticals
Lannett Company Inc
Pharmaceuticals
Vocera Communications Inc
Health Care
Walmart Inc
Retail
Physicians Realty Trust
Real Estate
Avanos Medical Inc
Health Care
NantHealth Inc
Health Care
Gilead Sciences Inc
Biotechnology
Upland Software Inc
Technology
Amgen Inc
Biotechnology
OptiNose Inc
Pharmaceuticals
Eagle Pharmaceuticals Inc
Biotechnology
Viatris Inc
Pharmaceuticals
Alphabet Inc
Media
Aerie Pharmaceuticals Inc
Pharmaceuticals
BIO-Key International Inc
Technology
Omeros Corp
Pharmaceuticals
E
Elevation Oncology Inc
Biotechnology
SPAR Group Inc
Media
Vanda Pharmaceuticals Inc
Biotechnology
Exelixis Inc
Biotechnology
Akebia Therapeutics Inc
Biotechnology
CRA International Inc
Professional Services
Rigel Pharmaceuticals Inc
Biotechnology
Moderna Inc
Biotechnology
Qualigen Therapeutics Inc
Biotechnology
TherapeuticsMD Inc
Pharmaceuticals
EyePoint Pharmaceuticals Inc
Pharmaceuticals
Vertex Pharmaceuticals Inc
Biotechnology
A
Assertio Holdings Inc
Pharmaceuticals
OneSpan Inc
Technology
A
Augmedix Inc
Health Care
A
ANI Pharmaceuticals Inc
Pharmaceuticals
Walgreens Boots Alliance Inc
Retail
P
Puma Biotechnology Inc
Biotechnology
A
Antares Pharma Inc
Pharmaceuticals
Pacira Biosciences Inc
Pharmaceuticals
Supernus Pharmaceuticals Inc
Pharmaceuticals
Regeneron Pharmaceuticals Inc
Biotechnology
A
Amphastar Pharmaceuticals Inc
Pharmaceuticals
Omniq Corp
Technology
Eton Pharmaceuticals Inc
Pharmaceuticals
Blackline Inc
Technology
T
Teligent Inc (NEW JERSEY)
Pharmaceuticals
Seagen Inc
Biotechnology
R
RVL Pharmaceuticals PLC
Pharmaceuticals
Dexcom Inc
Health Care
Suppliers Map

Mckesson Corp has 10 key customers from 2 countries and 3 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Retail industry.

Ownership

MCK Insider Trading
Buy and sell transactions by insiders

Mckesson Corp insiders have only sold shares in the past 12 months.

During the last 12 months Mckesson Corp insiders have not bought any shares, and sold 56.3M USD worth of shares. The last transaction was made on Dec 10, 2022 by Schechter Lori A. (EVP, Chief Legal Officer & GC), who sold 978k USD worth of MCK shares.

Sold
0-3
months
8M USD
2
3-6
months
3.4M USD
2
6-9
months
40.4M USD
6
9-12
months
4.5M USD
3
Bought
0-3
months
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
8M USD
N/A
-8M
6 Months
11.4M USD
N/A
-11.4M
9 Months
51.8M USD
N/A
-51.8M
12 Months
56.3M USD
N/A
-56.3M
Purchases
4
Sales
639
Why is insider trading important?

Shareholder Return

MCK Price
Mckesson Corp

1M 1M
+0%
6M 6M
+19%
1Y 1Y
+60%
3Y 3Y
+167%
5Y 5Y
+153%
Annual Price Range
371.44
52w Low
228.57
52w High
397.58
Price Metrics
Average Annual Return 6.62%
Standard Deviation of Annual Returns 25.45%
Max Drawdown -38%
Shares Statistics
Market Capitalization 52.7B USD
Shares Outstanding 143 581 000
Percentage of Shares Shorted 1.97%

Company Profile

Mckesson Corp

Country

United States of America

Industry

Health Care

Market Cap

52.7B USD

Dividend Yield

0.56%

Description

McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. The company is headquartered in Irving, Texas and currently employs 59,000 full-time employees. The firm is focused on providing health information technology, and care management tools. The Company’s segments include U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment provides distribution and logistics services for branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. The International segment provides services to wholesale, institutional, in 13 European countries and Canada. Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. RxTS segment combines its technologies, including CoverMyMeds, RelayHealth, RxCrossroads, and McKesson Prescription Automation, to serve its biopharma and life sciences partners and patients.

Contact

TEXAS
Irving
6555 State Highway 161
+19724464800.0
http://www.mckesson.com/

IPO

1994-11-10

Employees

59 000

Officers

CEO & Director
Mr. Brian S. Tyler Ph.D.
Exec. VP & CFO
Mr. Britt J. Vitalone
Exec. VP, Chief Information Officer & CTO
Ms. Nancy Avila
Exec. VP, Chief Legal Officer & Gen. Counsel
Ms. Lori A. Schechter J.D.
Exec. VP & Chief HR Officer
Ms. Tracy L. Faber
Sr. VP, Controller & Chief Accounting Officer
Mr. Napoleon B. Rutledge Jr.
Show More
Sr. VP of Investor Relations
Ms. Holly Weiss
Sr. VP of Corp. Public Affairs
Mr. Pete Slone
Pres of The US Pharmaceutical & Specialty Solutions Bus.
Mr. Kirk Kaminsky
Sr. VP of Taxes
Paul A. Smith
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one MCK stock?

The intrinsic value of one MCK stock under the Base Case scenario is 614.47 USD.

Is MCK stock undervalued or overvalued?

Compared to the current market price of 371.44 USD, Mckesson Corp is Undervalued by 40%.